BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 27723895)

  • 1. Effects of Long-term Serial Passaging on the Characteristics and Properties of Cell Lines Derived From Uveal Melanoma Primary Tumors.
    Mouriaux F; Zaniolo K; Bergeron MA; Weidmann C; De La Fouchardière A; Fournier F; Droit A; Morcos MW; Landreville S; Guérin SL
    Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5288-5301. PubMed ID: 27723895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of Mart-1 in human uveal melanoma cells.
    Wang J; Jia R; Yao Y; Cun B; Huang X; Gu P; Ge S; Fan X
    Mol Med Rep; 2011; 4(5):799-803. PubMed ID: 21667026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the proteasome activity and the turnover of the serotonin receptor 2B (HTR2B) in human uveal melanoma.
    Le-Bel G; Benhassine M; Landreville S; Guérin SL
    Exp Eye Res; 2019 Jul; 184():72-77. PubMed ID: 31002821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of RASSF1A in uveal melanoma.
    Dratviman-Storobinsky O; Cohen Y; Frenkel S; Merhavi-Shoham E; El SD; Binkovsky N; Pe'er J; Goldenberg-Cohen N
    Invest Ophthalmol Vis Sci; 2012 Oct; 53(6):2611-9. PubMed ID: 22447862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIC1 modulates uveal melanoma progression by activating lncRNA-numb.
    Cheng G; He J; Zhang L; Ge S; Zhang H; Fan X
    Tumour Biol; 2016 Sep; 37(9):12779-12789. PubMed ID: 27449031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAUPAR lncRNA suppresses tumourigenesis by H3K4 demethylation in uveal melanoma.
    Ding X; Wang X; Lin M; Xing Y; Ge S; Jia R; Zhang H; Fan X; Li J
    FEBS Lett; 2016 Jun; 590(12):1729-38. PubMed ID: 27214741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered expression of the poly(ADP-ribosyl)ation enzymes in uveal melanoma and regulation of PARG gene expression by the transcription factor ERM.
    Molloy-Simard V; St-Laurent JF; Vigneault F; Gaudreault M; Dargis N; Guérin MC; Leclerc S; Morcos M; Black D; Molgat Y; Bergeron D; de Launoit Y; Boudreau F; Desnoyers S; Guérin S
    Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6219-31. PubMed ID: 22915039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the metastasis suppressor gene KISS1 in uveal melanoma.
    Martins CM; Fernandes BF; Antecka E; Di Cesare S; Mansure JJ; Marshall JC; Burnier MN
    Eye (Lond); 2008 May; 22(5):707-11. PubMed ID: 18219339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autocrine impact of VEGF-A on uveal melanoma cells.
    Koch KR; Refaian N; Hos D; Schlereth SL; Bosch JJ; Cursiefen C; Heindl LM
    Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2697-704. PubMed ID: 24677103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between clinical features, GEP class, and PRAME expression in uveal melanoma.
    Schefler AC; Koca E; Bernicker EH; Correa ZM
    Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1541-1545. PubMed ID: 31065847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the serotonin receptor 2B in uveal melanoma and effects of an antagonist on cell lines.
    Weidmann C; Bérubé J; Piquet L; de la Fouchardière A; Landreville S
    Clin Exp Metastasis; 2018 Mar; 35(3):123-134. PubMed ID: 29696577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Verification of EZH2 as a druggable target in metastatic uveal melanoma.
    Jin B; Zhang P; Zou H; Ye H; Wang Y; Zhang J; Yang H; Pan J
    Mol Cancer; 2020 Mar; 19(1):52. PubMed ID: 32127003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of nm23-H1 in uveal melanoma.
    Bakalian S; Marshall JC; Faingold D; Logan P; Antecka E; Burnier MN
    Melanoma Res; 2007 Oct; 17(5):284-90. PubMed ID: 17885583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Long Non-Coding RNA RHPN1-AS1 Promotes Uveal Melanoma Progression.
    Lu L; Yu X; Zhang L; Ding X; Pan H; Wen X; Xu S; Xing Y; Fan J; Ge S; Zhang H; Jia R; Fan X
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28124977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA m
    Luo G; Xu W; Zhao Y; Jin S; Wang S; Liu Q; Chen X; Wang J; Dong F; Hu DN; Reinach PS; Yan D
    J Cell Physiol; 2020 Oct; 235(10):7107-7119. PubMed ID: 32017066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel mouse model for primary uveal melanoma: a pilot study.
    Süsskind D; Hurst J; Rohrbach JM; Schnichels S
    Clin Exp Ophthalmol; 2017 Mar; 45(2):192-200. PubMed ID: 27505446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repression of genes involved in melanocyte differentiation in uveal melanoma.
    Bergeron MA; Champagne S; Gaudreault M; Deschambeault A; Landreville S
    Mol Vis; 2012; 18():1813-22. PubMed ID: 22815634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Grb2-associated binder 2 expression and its roles in uveal melanoma invasion.
    Chen M; Li Y; Sun X; Zhang B; Li W; Wang S; Zhu X; Li F; Shi L
    Mol Med Rep; 2017 Oct; 16(4):4577-4582. PubMed ID: 28791340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of the STAT Family of Transcription Factors to the Expression of the Serotonin 2B (HTR2B) Receptor in Human Uveal Melanoma.
    Benhassine M; Le-Bel G; Guérin SL
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EMT-associated factors promote invasive properties of uveal melanoma cells.
    Asnaghi L; Gezgin G; Tripathy A; Handa JT; Merbs SL; van der Velden PA; Jager MJ; Harbour JW; Eberhart CG
    Mol Vis; 2015; 21():919-29. PubMed ID: 26321866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.